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The genes of the lic1 operon (lic1A to lic1D) are responsible for incorporation of phosphocholine (PCho) into
the lipopolysaccharide (LPS) of Haemophilus influenzae. PCho plays a multifaceted role in the commensal and
pathogenic lifestyles of a range of mucosal pathogens, including H. influenzae. Structural studies of the LPS of
nontypeable H. influenzae (NTHI) have revealed that PCho can be linked to a hexose on any one of the
oligosaccharide chain extensions from the conserved inner core triheptosyl backbone. In a collection of NTHI
strains we found several strains in which there were two distinct but variant lic1D DNA sequences, genes
predicted to encode the transferase responsible for directing the addition of PCho to LPS. The same isolates
were also found to express concomitantly two PCho residues at distinct positions in their LPS. In one such
NTHI isolate, isolate 1158, structural analysis of LPS from lic1 mutants confirmed that each of the two copies
of lic1D directs the addition of PCho to a distinct location on the LPS. One position for PCho addition is a novel
heptose, which is part of the oligosaccharide extension from the proximal heptose of the LPS inner core.
Modification of the LPS by addition of two PCho residues resulted in increased binding of C-reactive protein
and had consequential effects on the resistance of the organism to the killing effects of normal human serum
compared to the effects of glycoforms containing one or no PCho. When bound, C-reactive protein leads to
complement-mediated killing, indicating the potential biological significance of multiple PCho residues.
Phosphocholine (PCho) has been detected on the cell sur-
face of a range of bacteria, predominantly bacteria residing in
the human respiratory tract, such as Haemophilus influenzae (5,
25, 39). In H. influenzae, PCho is a substituent of the lipopoly-
saccharide (LPS) molecule (24, 25, 39), the main glycolipid on
the bacterial cell surface that is a target for host immune
responses and influences both the commensal and pathogenic
behavior of the organism (38). H. influenzae LPS comprises a
membrane-anchoring lipid A (endotoxin) linked to oligosac-
charide chains that extend from the bacterial cell surface. The
LPS of a number of different strains have been analyzed and
have been shown to be composed of a common L-glycero-D-
manno-heptose-containing inner-core trisaccharide unit at-
tached to the lipid A via a phosphorylated 2-keto-3-deoxyoc-
tulosonic acid (Kdo) residue (20, 23). Each of the heptose
(Hep) residues can provide a point for addition of a hexose
(Hex) residue, which in turn can lead to oligosaccharide chain
extension (for a review, see reference 28). The nature of the
oligosaccharide chains and the degree to which they contain
noncarbohydrate substituents, such as PCho, show intra- and
interstrain variation that can affect the virulence of the organ-
ism. PCho in H. influenzae LPS plays a role in persistence of
the bacterium on the mucosal surface of the nasopharynx, at
least in part by mediating bacterial adherence to, and invasion
of, the host epithelia (38), which has been shown to occur
through the receptor for platelet-activating factor on bronchial
epithelial cells (30). PCho expressed on the LPS of the organ-
ism is the target for the serum component C-reactive protein
(CRP), which, when bound, mediates killing of the bacteria via
activation of complement (37, 38). PCho expression on the
LPS of H. influenzae has also been associated with increased
resistance to host antimicrobial peptide killing (18).
Several of the surface-exposed epitopes of H. influenzae LPS
are subject to high-frequency phase variation, an adaptive
mechanism that is advantageous for survival of bacteria con-
fronted by the different microenvironments and immune re-
sponses of the host (22). Tetranucleotide repeat tracts in a
number of LPS biosynthesis genes mediate this phase variation
through slippage mechanisms (9, 11, 34, 36). The genes respon-
sible for incorporation of PCho on the LPS of H. influenzae are
the genes of the lic1 operon, which consists of four open
reading frames (lic1A to lic1D) (33). A 5CAAT tetranucle-
otide repeat is located just within the 5 end of the lic1A
reading frame, making addition of PCho to the LPS subject to
phase variation (34). Choline incorporation in H. influenzae
occurs via the transport of choline from the host environment
by Lic1B, phosphorylation of choline by Lic1A, activation of
PCho via a pyrophosphorylase, Lic1C, and transfer of the ac-
tivated PCho to the LPS by Lic1D (39). PCho is also present on
the cell surface of a number of other major pathogens residing
in the human respiratory tract, such as Streptococcus pneu-
moniae and Neisseria meningitidis (13, 21, 32), suggesting that
* Corresponding author. Mailing address: School of Molecular and
Microbial Sciences, The University of Queensland, Brisbane, QLD
4072, Australia. Phone: (61) 73365 1892. Fax: (61) 73365 4620. E-mail:
k.fox@uq.edu.au.
 Published ahead of print on 5 November 2007.
588
 o
n
 O
ctober 18, 2015 by University of Queensland Library
http://iai.asm
.org/
D
ow
nloaded from
 
this structure may contribute to the ability of these species to
occupy their niche on the host mucosal surface. Phase-variable
expression of PCho is also common in other bacteria (12, 29,
32, 35).
Structural studies of H. influenzae LPS have demonstrated
that PCho can be linked to hexoses attached to any one of the
three heptoses (19, 25, 27). Lysenko and colleagues have
shown that the lic1D gene directs this addition and that the
location of the PCho molecule can alter the susceptibility of
the bacteria to CRP-mediated bacterial killing (17). In this
study we found that the presence of two distinct PCho epitopes
located in the same LPS molecule in a limited subset of non-
typeable H. influenzae (NTHI) strains is due to the presence of
two distinct copies of the lic1 operon in these strains. Further,
the lic1D sequence in each operon is responsible for directing
PCho addition to unique sites in the LPS. One of the additions,
in which PCho is added to a heptose that is part of the oligo-
saccharide extension from the proximal heptose of the LPS
inner core, is novel.
MATERIALS AND METHODS
Bacterial strains and culture conditions. Twenty-six NTHI isolates used in this
study, designated isolates 162, 176, 285, 375, 432, 477, 486, 667, 723, 981, 1003,
1008, 1124, 1158, 1159, 1180, 1181, 1200, 1207, 1209, 1231, 1232, 1233, 1247,
1268, and 1292, were obtained from the Finnish Otitis Media Study Group.
Isolates were obtained from the middle ear and were selected as organisms that
are representative of the genetic diversity of H. influenzae after ribotyping anal-
ysis (2). Isolate 176, as described in this study, is distinct from that described in
reference 27, which actually referes to isolate 1292. H. influenzae was grown at
37°C in brain heart infusion (BHI) broth supplemented with hemin (10 g/ml)
and NAD (2 g/ml). BHI medium plates were prepared with 1% agar, and they
were supplemented with 10% Levinthals base (1) and, when appropriate, tetra-
cycline (4 g/ml) or chloramphenicol (2 g/ml). Escherichia coli strain DH5 was
used to propagate plasmids and was grown at 37°C in LB broth (26) supple-
mented, when appropriate, with ampicillin (100 g/ml), tetracycline (12 g/ml),
or chloramphenicol (30 g/ml).
Cloning of lic1* and mutation of lic1D*. The novel lic1 locus (lic1*) of isolate
1158 was identified as a lic1D-hybridizing 1.9-kb band and a lic1A-hybridizing
2.9-kb band in MfeI-digested DNA by Southern analysis. The 1.9-kb fragment of
lic1* was included in a 1.5- to 2.3-kb size fraction of DNA extracted and purified
from the agarose gel and then cloned into plasmid pUC18. E. coli transformants
were colony blotted and hybridized with a lic1D-specific probe to identify plas-
mid pAD. The insert from the plasmid was confirmed to contain lic1-specific
sequences by PCR and Southern analyses (Table 1). The 2.9-kb MfeI lic1*-
hybridizing fragment was similarly cloned from 2.5- to 3.5-kb size-fractionated
chromosomal DNA to obtain plasmid pAE.
The cloned lic1D* gene from NTHI isolate 1158, in plasmid pAD, was dis-
rupted by replacement of a 663-bp EcoRV restriction fragment (spanning bp 46
to 709 in the 807-bp lic1D* gene) with a blunt-ended chloramphenicol resistance
cassette released from pACYC184 (14), resulting in plasmid pAD1cat1 (Fig. 1).
FIG. 1. Schematic representation of the construction of pUC19lic1D*::cat and subsequent transformation into H. influenzae. (A) Insertion of
the chloramphenicol resistance (cat) cassette into the lic1D* open reading frame. (B) Transformation into NTHI isolate 1158. (C) Homologous
recombination results in exchange of the plasmid insert with lic1D on the 1158 chromosome, producing 1158lic1D*::cat mutants. The binding sites
for primers used for screening transformants are shown in panel C.
TABLE 1. Primers used in this study for PCR amplification and DNA sequencing of pAD and for verification of lic1 mutant strains and the
lic1 tandem duplication
Primer Sequence Open reading frame containingprimer binding site
Orientation of primer binding
site with respect to open
reading frame
LIB1 5TAACGCAGTATATTCAC3 lic1B Reverse
1158lic1DA 5GGATCATTAAACCAGCCTATTGAC3 lic1D Forward
1158lic1DB 5TTGTATTGTTTGAATTGTGGGAAG3 lic1D Reverse
1158lic1Dr 5GAAGTTGCATATAGTCGCCGTA3 lic1D Reverse
lic1DA 5GTGATGATATATTTGAAATG3 lic1D Forward
lic1Dr 5TGGAAGCTTCATATAATCTCCATAA3 lic1D Reverse
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After transformation into E. coli, mutant strains were confirmed by restriction
and PCR analyses (Table 1).
Construction of lic1 mutant strains of NTHI. lic1 mutants strains of NTHI
isolates 176, 1158, and 1159 were constructed by transformation using DNA in
which the whole lic1 operon was disrupted by deletion of part or all of lic1A
through lic1D and replacement with a tetracycline resistance cassette (40) (Fig.
2). A mutant strain in which the lic1D* gene had been specifically targeted and
disrupted in NTHI isolate 1158 was constructed by transformation with linear-
ized plasmid pAD1cat1 described above. All H. influenzae transformations were
carried out using the MIV procedure (8). Transformants were confirmed by
culturing on the appropriate selective media and by PCR analyses using primer
sets specific for each copy of the lic1D gene (Tables 1 and 2).
Analysis of LPS by electrophoresis. Bacterial lysates were prepared from cells
grown overnight on BHI medium plates and then suspended in phosphate-
buffered saline (PBS) at an absorbance at 260 nm of 1. Lysates were analyzed by
Tricine-sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis
(PAGE) (16) and staining with silver (Quicksilver; Amersham Pharmacia).
Immunoblot analysis using MAbs TEPC15 and 12D9. A single H. influenzae
colony was resuspended in PBS, serially diluted, and plated to obtain approxi-
mately 1  103 and 5  103 colonies per plate. Either single colonies or streaks
of bacterial growth were transferred onto a Protran nitrocellulose filter (Schlei-
cher & Schuell) and air dried. Nonspecific binding sites were blocked with
PBS–0.05% (vol/vol) Tween 20 and 2% (wt/vol) bovine serum albumin. The filter
was then incubated with monoclonal antibody (MAb) TEPC15 or 12D9. Primary
antibody was detected with either an immunoglobulin G (IgG)-specific antibody
for MAb 12D9 or an IgA-specific antibody for MAb TEPC15 conjugated to
alkaline phosphatase. Bound antibody was detected with 5-bromo-4-chloro-3-
indolylphosphate (BCIP) and nitroblue tetrazolium (NBT) (Perkin Elmer Life
Sciences).
Western blot analysis of LPS using MAb TEPC15. Bacterial lysates were
boiled in dissociation buffer and then separated by 16.5% Tricine-SDS-PAGE.
After transfer from the gel to a nitrocellulose membrane (Schleicher & Schuell),
membranes were blocked and then incubated with MAb TEPC15. Primary an-
tibody was detected using an IgA antibody conjugated to alkaline phosphatase
and developed using BCIP and NBT (Perkin Elmer Life Sciences).
Structural analysis of LPS. The structure of LPS was elucidated using proce-
dures described previously (41). Briefly, reduced core oligosaccharide material
was obtained after mild acid hydrolysis (1% aqueous acetic acid [pH 3.1] 100°C,
2 h) and simultaneous reduction of LPS following centrifugation and purification
by gel chromatography. Oligosaccharide was dephosphorylated using 48% hy-
drogen fluoride and then was permethylated using methyl iodide in dimethyl
sulfoxide in the presence of lithium methylsulfinylmethanide. O deacylation was
performed using 1% aqueous ammonia at 20 to 22°C for 10 h. Liquid chroma-
tography (LC)–multiple-step tandem electrospray ionization mass spectrometry
(ESI-MSn) in the positive-ion mode was performed with a Waters 2690 high-
performance liquid chromatography system (Waters, Milford, MA) coupled to a
Finnigan LCQ ion trap mass spectrometer (Finnigan-MAT, San Jose, CA) as
described previously (7). Capillary electrophoresis (CE)-ESI-MS experiments
were carried out with a Prince CE system (Prince Technologies, The Nether-
lands) coupled to either an API 3000 mass spectrometer (Applied Biosystems/
MDS Sciex, Concord, Canada) or a 4000 QTRAP mass spectrometer (Applied
Biosystems/MDS Sciex, Concord, Canada) as described previously (41).
Binding of CRP to H. influenzae strains expressing different amounts of PC.H.
influenzae strains were grown to an optical density at 620 nm of 0.4, washed in
PBS, and resuspended in 2 volumes of normal human serum which had been heat
inactivated by incubation at 56°C for 30 min, and 1 g of purified human CRP
(Sigma) per 108 cells was added. After incubation with agitation for 15 min at
37°C, the cells were washed in PBS and resuspended in gel loading buffer.
Samples were boiled for 5 min and separated by 16% Tricine-SDS-PAGE (In-
vitrogen). After transfer from the gel to nitrocellulose membranes (Protran), the
membranes were blocked, and then bound CRP was detected using an MAb
against human CRP (Sigma). Primary antibody was detected using an IgG
anti-mouse antibody conjugated to alkaline phosphatase and developed using
BCIP and NBT (Perkin Elmer Life Sciences).
Serum bactericidal assay. Bacteria cultured on BHI medium plates were
resuspended in PBS, and the concentration was adjusted to104 cells/ml. A total
of 5  102 organisms were then added to doubling dilutions of pooled normal
FIG. 2. Schematic representation of the construction of pUC19lic1::tet and subsequent transformation into H. influenzae, adapted from
reference 40 with permission. (A) Insertion of the tet cassette into the lic1 locus. (B) Transformation into NTHI isolate 1159. (C) Homologous
recombination results in exchange of the plasmid insert with lic1 on the 1159 chromosome, producing 1159lic1::tet mutants. The binding sites for
primers used in screening transformants are shown in panel C.
TABLE 2. PCR analysis of lic1 mutants in NTHI isolates 176, 1158,
and 1159, using primer sets specific for each copy of the lic1D gene
Strain
Presence of PCR product with primersa:
lic1DA and lic1Dr
(lic1 specific)
1158lic1DA and 1158lic1Dr
(lic1* specific)
176  
176lic1  
1158  
1158lic1  
1159lic1  
1158lic1D*   (1.1 kb)
a PCR amplification products were 800 bp long unless indicated otherwise.
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human serum (0.15 to 10%) in PBS containing 0.1% glucose, as previously
described (10). After 45 min of incubation at 37°C, the survival of bacteria at
each serum concentration was determined by plating and culturing. CRP was
removed from the pooled human serum using PCho-coated beads as described
previously (17).
Adhesion to airway epithelial cells. The adherence of H. influenzae strains to
cultured human bronchial epithelial cells (16HBE14o) was studied by using a
method similar to a method described previously (10, 31).
RESULTS
Some strains of H. influenzae have duplicated sequences of
the lic1 operon. In a recent survey of tetranucleotide repeat
tracts in H. influenzae, Southern blots of restriction endonu-
clease-digested DNA from 25 NTHI isolates were probed with
20-base oligonucleotides representing all possible tetranucle-
otide repeat sequences. Seven to 16 hybridizing bands were
found for each isolate (4). Repeat tracts were investigated
further by stripping the blots and reprobing them with se-
quences representing the various genes that are known to be
associated with tetranucleotide repeats; in this way it was pos-
sible to identify novel candidate genes associated with repeats.
In the case of the oligonucleotide probe (5CAAT)5, three
previously reported LPS-related genes, lic1A, lic2A, and lic3A,
were identified in each strain, but up to five (5CAAT)5-hy-
bridizing bands were obtained for a minority of NTHI strains.
An additional DNA band was identified for four NTHI iso-
lates, isolates 176, 1008, 1158, and 1159, and this band cohy-
bridized to a (5CAAT)5 repeat oligonucleotide and to sepa-
rate probes containing lic1A and lic1D gene sequences (Fig. 3).
Isolates 1158 and 1159 were chosen for closer analysis since the
detailed structure of the LPS was available for these isolates
and two PCho residues are present at distinct locations. Iso-
lates 1158 and 1159 are believed to be independent isolates of
the same strain (2).
Cloning of the duplicated lic1 sequence shows that it is novel
and differs from the original lic1 gene. Two copies of lic1-
specific sequences were identified in NTHI isolate 1158 by
Southern hybridization. An MfeI digest of chromosomal DNA
from NTHI isolate 1158 contained 4.9- and 2.9-kb fragments
which hybridized to a (5CAAT)5 and lic1A probe; 3- and
1.9-kb fragments hybridized to a lic1D probe (Fig. 3). Southern
analysis of MfeI-digested chromosomal DNA from strain Rd
revealed a 4.9-kb band that hybridized to lic1A and a 3-kb band
that hybridized to lic1D, consistent with fragment sizes pre-
dicted from the genome sequence. Our interpretation of this
was that the 2.9-kb lic1A-hybridizing band and the 1.9-kb
lic1D-hybridizing band observed with isolate 1158 likely corre-
sponded to the second “non-Rd-like” lic1 copy of interest. The
second copy of lic1 was designated lic1*.
To investigate these sequences further, we cloned what was
hypothesized to be the second, or duplicate, sequence. The
1.9-kb fragment of lic1* was cloned in E. coli to obtain plasmid
pAD. The DNA sequence of the cloned insert of pAD was
obtained and compared to the sequence in the H. influenzae
genome database using the BLAST algorithm (3). The cloned
insert of pAD was found to contain sequences with homology
to lic1B, lic1C, and lic1D (HI1538 to HI1540, respectively) and,
unexpectedly, to sppA (HI1541), the gene adjacent to lic1D in
the strain Rd genome sequence. From these sequence com-
parisons two possible conclusions could be drawn: either the
copy of lic1 cloned from 1158 was equivalent to the copy found
FIG. 3. Southern blot of MfeI-digested chromosomal DNA isolated from 25 NTHI isolates and then probed with DNA fragments of the lic1
locus. The blot contained (from left to right) the 25 NTHI isolates in ascending numerical order and our control H. influenzae strains, Eagan, Rd,
and RM7004. The probes used were lic1A (A) and lic1D (B). The positions of lic1A- and lic1D-hybridizing bands of interest are indicated by arrows.
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in strain Rd due to an “Rd-like” gene arrangement, or it
represented a second copy in which the duplication extended
further than the lic1 operon itself. To further examine the
DNA flanking this copy of the lic1 operon, the Southern blot of
MfeI-digested chromosomal DNA was hybridized using a 3
segment of the sppA gene as a probe. This probe hybridized to
both lic1D bands in DNA from isolates 1158 and 1159. Since a
segment of sppA appeared to be associated with both copies of
lic1 in isolate 1158, adjacent genes both upstream and down-
stream of lic1 were used as hybridization probes (Table 3) to
examine the extent of the duplication.
First, a 5 segment of the sppA gene (HI1541) was used as a
probe. There is an MfeI site in this region of DNA in the Rd
genome sequence, so two hybridizing bands would be expected
for strain Rd. For isolates 1158 and 1159, four hybridizing
bands were seen, confirming that the sppA gene is duplicated in
these isolates. The next gene downstream of sppA in Rd,
HI1542, was also used as a hybridization probe, but the results
were inconclusive. Hybridization with the HI1543 gene defined
the 3 end of the duplication, giving a single hybridizing band
for the isolates. The gene immediately upstream of lic1 in the
Rd genome sequence, HI1536, was found to be duplicated in
NTHI isolates 1158 and 1159; however, the HI1535 gene was
not duplicated, thus defining the 5 end of the duplication. To
locate lic1* within the genome, the 2.9-kb band from the MfeI
digest of isolate 1158 DNA, predicted to contain the second
copy of lic1A* (HI1537), was cloned and sequenced, and the
sequence was used to search the H. influenzae strain Rd ge-
nome database. The sequence of the insert contained DNA
with homology to sppA (HI1541) at one end and to lic1B
(HI1538) at the other end, indicating that there is a tandem
duplication of the lic1 locus in isolate 1158 (Fig. 4B). Further
confirmation of the presence of a tandem duplication of the
lic1 locus came from a PCR analysis using a lic1D forward
primer (1158lic1DA) and a lic1B reverse primer (L1B1) (Fig.
4). The results revealed a 4-kb amplification product in isolates
1158 and 1159.
Duplicated lic1 sequence is different from the sequence of
the original lic1 locus. The two Lic1D sequences from NTHI
isolate 1158 were compared (Fig. 5) and found to be 78.9%
similar and 74.1% identical. The sequence of lic1D* is diver-
gent from any lic1D sequence described in a survey of the same
25 NTHI isolates by multilocus sequence typing of a number of
LPS biosynthetic genes (2). When 20 Lic1D sequences were
aligned, three major subgroups which correlated with the hex-
ose extension to which PCho addition is directed were identi-
fied (i.e., off HepI, HepII, and HepIII) (data not shown).
Preliminary structural analysis of NTHI isolate 1158 LPS in-
dicated the presence of two PCho residues, one linked directly
to the hexose off HepIII and the other in a unique location
linked to the Hep (designated HepIV) as part of the oligosac-
charide extension from HepI. The sequence of Lic1D* likely
constitutes a fourth subgroup of sequences in which the addi-
tion of PCho is addition to a HepIV residue. The Lic1D*
sequence contains two amino acid residues that differ from the
residues in any of the other Lic1D sequences analyzed. Both of
these residues are located in the EcoRV fragment of DNA
used by Lysenko and colleagues (17) in transformation exper-
iments that resulted in a change in the lic1D sequence and an
altered location of PCho in the LPS. The Thr-95 and His-144
residues in Lic1D* are different from the conserved Ala-95 and
Arg-144 residues at the equivalent positions in all other Lic1D
sequences analyzed. The sequence of Lic1D from isolate 1158
aligns with the HepIII-like sequences (data not shown), con-
sistent with the hypothesis that Lic1D is responsible for addi-
tion of PCho to the hexose attached to HepIII.
The second copy of lic1 was also investigated in NTHI iso-
lates 176 and 1008. PCR amplification with primers
1158lic1DA and L1B1 resulted in a 1.8-kb product with isolate
1008 (data not shown). HI1541 (sppA) was found by Southern
analysis not to be duplicated in this isolate, and the size of the
PCR product likely indicates that the lic1* operon is also
truncated. This would be consistent with the fact that two
FIG. 4. Model of the organization of the lic1 tandem duplication in
NTHI isolate 1158. (A) Schematic representation of the lic1 operon
and surrounding genes in the strain Rd genome. (B) Organization of
the lic1 duplication in NTHI isolate 1158. Block arrows represent
ORFs, and the direction of an arrow indicates the relative direction of
transcription. The lic1 operon is represented by shaded block arrows.
TIGR accession numbers are indicated in the arrows, and gene des-
ignations are indicated below the arrows. Rectangles in panel B rep-
resent partial open reading frames compared to the strain Rd genome
sequence (sppA had a 147-bp truncation at the 5 end, only 37 bp at the
5 end of HI1542 was present, and only 85 bp at the 3 end of HI1535
was present in the region between the two lic1 operons in the genome
of NTHI isolate 1158). The small horizontal arrows indicate the posi-
tions and directions of primers L1B1 (within lic1B) and 1158lic1DA
(within lic1D). The positions of MfeI restriction sites are indicated by
vertical arrows. In panel B the region of DNA corresponding to the
cloned insert within plasmids pAD and pAE is indicated.
TABLE 3. Primers used in this study for PCR amplification of genes
flanking lic1, which were used as probes in Southern analysis
Gene
amplified Primer Sequence
HI1535 5HI1535 5TTCGTTTCACGAAACCCAAT3
3HI1535 5TATCCACATCTTGCGTCCAA3
HI1536 5HI1536 5ATCTCGCTCGTGTAGGCATT3
3HI1536 5TACCCAAGCTCGGTTAGCTG3
sppA sppA1 5GTGCATGCAGATGGTGTTTC3
3sppA 5GGCAAACCAAGCCATTTAAC3
HI1542 5HI1542 5TGCACCTAATGCAGAACAGC3
3HI1542 5CGATAACTCGGCATTCACG3
HI1543 5HI1543 5TCCAACAGATAAAGTACTCGCTGA3
3HI1543 5GCCAATATTTCTCGTGTAAGAAGG3
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PCho residues were not observed in a structural analysis of the
LPS from this isolate (unpublished results). In NTHI isolate
176, in which two PCho residues have been identified in the
LPS (E. Schweda, unpublished data), no PCR amplification
product was obtained with primers 1158lic1DA and L1B1. This
may indicate that the lic1 duplication is not in a tandem ar-
rangement in the genome of this isolate, that the duplication is
incomplete, or that the sequence of the second copy of lic1D is
different from that of isolate 1158. This heterogeneity is inter-
esting as it suggests that the duplication event may have oc-
curred independently in different isolates or may reflect the
instability of this region of DNA once the duplication has
occurred.
Analyses of the phenotype and antigenicity of lic1 mutants
show that the duplicated sequences have different properties.
Mutant strains of NTHI isolates 1158, 1159, and 176 were
constructed using DNA in which the whole lic1 operon was
disrupted by deletion of part or all of the lic1A, lic1B, lic1C,
and lic1D open reading frames and replacement with a tetra-
cycline resistance cassette (40) (Fig. 2). These mutant strains
were investigated by PCR amplification using primers designed
specifically to amplify one of the lic1D genes (primers lic1DA
and lic1Dr to amplify lic1D and primers 1158lic1DA and
1158lic1Dr to amplify lic1D*). The copy of lic1 mutated and
containing the antibiotic resistance cassette was indicated by
the absence of a PCR product with the corresponding specific
primer set, since the cassette replaced a fragment of the
operon including the lic1DA or 1158lic1DA primer binding
sites. For each mutant strain only one copy of the lic1 locus was
disrupted. In strains 176lic1 and 1159lic1, lic1 was disrupted,
whereas in strain 1158lic1, lic1* was disrupted (Table 2). Spe-
cific targeted disruption of the lic1D* gene was achieved by
replacement of a 663-bp EcoRV restriction fragment in lic1D*
in plasmid pAD with a chloramphenicol resistance cassette
(Fig. 1). Construct pAD1cat1 was used to transform NTHI
isolate 1158 to obtain transformant 1158lic1D*. This mutant
strain was also confirmed by PCR amplification using the
primer sets described above. Each primer set amplified an
800-bp internal fragment of the corresponding lic1D gene.
With transformant 1158lic1D* a 300-bp increase, due to loss
of an internal fragment and insertion of the antibiotic resis-
tance cassette, was observed with lic1*-specific primers, indi-
cating that lic1D* was disrupted (Table 2).
Bacterial lysates prepared from parental NTHI isolates and
the corresponding lic1 mutants were separated by Tricine-
SDS-PAGE, and representative LPS profiles are shown in Fig.
6A. A change in the LPS glycoforms, indicated by the number
of bands observed, was evident for wild-type isolates 1158 and
1159, each of which produced three major bands, for 1158lic1*
and 1158lic1D*, which produced four bands, and for 1159lic1,
which produced five distinct bands.
The set of lic1 mutants and their parent strains were com-
pared using immunoblot assays with LPS-specific MAbs 12D9
and TEPC15. MAb TEPC15 specifically recognizes PCho ir-
respective of its linkage and position, whereas MAb 12D9
discriminates based on the location of PCho within the LPS
molecule (17). NTHI isolates 1158, 1159, and 1158lic1 all re-
acted with MAbs TEPC15 and 12D9, whereas mutant strain
1159lic1 did not react with either MAb (data not shown). The
loss of PCho expression in mutant strain 1159lic1 was not due
to phase variation since the phenotype was irreversible (data
not shown). Instead, it was found to be due to deletion of 222
bp in the lic1C* gene of NTHI isolate 1159 compared to the
Rd lic1 sequence. The lic1C open reading frame is 699 bp long,
and the deletion in lic1C* spans the sequence from bp 455 to
677. Thus, the apparent irreversible loss of PCho expression
observed in mutant strain 1159lic1 was likely due to the lack of
a functional Lic1C gene product in this strain.
Western blot analysis of the same set of lic1 mutants indi-
cated that MAb TEPC15 reacted with all LPS bands in isolates
1158 and 1159 and in mutant strains 1158lic1* and 1158lic1D*,
indicating that PCho is expressed on the majority of glyco-
forms. The mobility differences in the banding patterns ob-
served for these strains is consistent with those expected due to
differences in the extent of modification with PCho. MAb
TEPC15 did not react with strain Rdlic1 or 1159lic1 (Fig. 6B),
confirming the findings of the immunoblot analysis.
Structural analysis of NTHI 1158 and 1159 LPS. The struc-
tures of LPS glycoforms from NTHI strains 1158 and 1159 were
determined by nuclear magnetic resonance and MS, and full
details will be reported separately. LPS from NTHI isolate 1158
was subjected to mild acid hydrolysis to obtain oligosaccharide
material. Part of this oligosaccharide material was dephosphoryl-
ated, permethylated, and analyzed by LC-ESI-MSn (7). The dom-
inant ion in the LC-ESI-MSn spectrum at m/z 1716 corresponded
to the sodiated adduct of a glycoform with the composition
Hex2  Hep4  anhydro-Kdo-ol (AnKdo-ol). The sequence of this
glycoform was established by performing MS-MS (MS2) and MS3
experiments, and the results confirmed the carbohydrate back-
bone of oligosaccharide shown in Fig. 7. CE-ESI-MS of the oli-
gosaccharide sample revealed predominant Hex2  Hep4 glyco-
forms in which the heterogeneity was due to the degree of
acetylation, glycylation, and/or phosphorylation. All glycoforms
comprised an AnKdo-ol formed during delipidation by -elimi-
FIG. 5. Alignment of amino acid sequences of Lic1D (A. Cody, personal communication) and Lic1D* in NTHI isolate 1158. Sequence
homology is indicated by a black background.
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nation of a pyrophosphoethanolamine (PPEtn) group from C-4
of Kdo as observed in previous studies (41). Of particular interest
were major ions at m/z 954.4, 975.5, and 997.5 (data not shown)
corresponding to glycoforms which each contained two PCho
substituents. Information concerning the location of PCho
in the oligosaccharide sample was provided by ESI-MS-MS
experiments in the positive-ion mode following online sep-
aration by capillary electrophoresis. The product ion spectrum
obtained from the doubly charged ion at m/z 844 (composition,
PCho  Ac2  Hex2  Hep4  PEtn  AnKdo-ol) (Fig. 7A) con-
tained marker ions at m/z 316, 328, and 370 corresponding to
PEtn  Hep, PCho  Hex, and PCho  Ac  Hex. Ions at m/z
1358 and 1124 corresponded to loss of PCho  Hex and PCho 
Ac  Hex  Hep, respectively, consistent with the hypothesis
that PCho is a substituent of the terminal hexose. The product
ion spectrum obtained from the doubly charged ion at m/z 954
(composition, PCho2  Ac2  Hex2  Hep4  PEtn  AnKdo-ol)
(Fig. 7B) contained, inter alia, the marker ions at m/z 358 and
400 corresponding to PCho  Hep and PCho  Ac  Hep, re-
spectively, to which additions of Hex (m/z 562), Hep (m/z 754),
and AnKdo-ol (m/z 976) could be seen. This provided evidence
that PCho replaced the terminal hexose as well the heptose in
the outer core.
Strains 1159lic1 and 1158lic1D* were analyzed by CE-ESI-MS.
In the CE-ESI-MS spectrum of 1158lic1D* (positive mode)
(Fig. 8A and Table 4), predominant ions corresponding to
PCho  Hex2  Hep4 glycoforms were observed, in which the het-
erogeneity was due to the degree of acetylation (Ac0-6) and glycy-
lation (Gly0-1). Major ions corresponding to glycoforms having
two PCho substituents were not observed. All ions corresponded
to glycoforms having one PCho (Table 4). The position of the
PCho substituent still expressed in this strain was established by
CE-ESI-MS-MS for ions at m/z 823 and 844 corresponding to the
composition PCho  Ac1,2  Hex2  Hep4  PEtn  AnKdo-ol. The
product ion spectrum for m/z 823 is shown in Fig. 8B. It contains
the marker ions at m/z 328 and 370 corresponding to PCho  Hex
and PCho  Ac  Hex. The product ion spectrum for m/z 843 was
virtually identical to that shown in Fig. 7A. None of the product
ion spectra contained m/z 358 or 400 corresponding to
PCho  Hep and PCho  Ac  Hep, respectively. It was therefore
evident that LPS purified from strain 1158lic1D*, containing a
disrupted copy of lic1D*, lacked PCho off HepIV but retained
FIG. 6. Western blot analysis using MAb TEPC15 with LPS from NTHI isolates 176, 1158, and 1159 and the corresponding lic1 mutant strains,
176lic1, 1158lic1*, 1158lic1D* (four independent mutants [1158lic1D*1 to 1158lic1D*4]), 1159lic1, and H. influenzae mutant strain Rdlic1. (A) LPS
profile prior to blotting. (B) Western blot with MAb TEPC15.
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PCho off the HepIII extension. It is noteworthy, however, that a
precursor ion-monitoring tandem MS experiment (positive-ion
mode) (data not shown) scanning for loss of m/z 358
(PCho  Hep) on O-deacylated 1158lic1D* showed ions at m/z
803 and 885.5 corresponding to PCho1,2  Hex2  Hep4  PEtn 
AnKdo-ol. From the abundance of these ions it could be con-
cluded that these glycoforms accounted for about 1 and 0.4% of
the total glycoforms. Thus, an lic1D* mutation certainly effects
FIG. 7. CE-ESI-MS2 (positive mode) analyses of the oligosaccharide from NTHI isolate 1158. (A) Product ion spectrum of [M2H]2 m/z 843
corresponding to PCho  Ac2  Hex2  Hep4  PEtn  AnKdo-ol. (B) Product ion spectrum of [M2H]
2 m/z 954 corresponding to
PCho2  Ac2  Hex2  Hep4  PEtn  AnKdo-ol. The proposed carbohydrate backbone and selected fragments are indicated.
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FIG. 8. CE-ESI-MS2 (positive mode) analyses of the oligosaccharide from the NTHI isolate 1158lic1D* mutant strain. (A) Part of the
CE-ESI-MS spectrum (positive mode) of the oligosaccharide from strain 1158lic1D*. (B) Product ion spectrum of [M2H]2 m/z 823 corre-
sponding to PCho  Ac  Hex2  Hep4  PEtn  AnKdo-ol. The proposed carbohydrate backbone and selected fragments are indicated.
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PCho substitution at HepIV but may also show the promiscuity of
lic1D. Mutant strain 1159lic1, shown by PCR amplification to
contain a disrupted copy of the complete lic1 locus, displayed no
detectable PCho on its LPS. Structural analysis was also carried
out for the LPS of the lic1 mutant strain of NTHI isolate 176. Like
isolate 1158 LPS, isolate 176 LPS displays PCho linked to the first
hexose in the chain extension from HepIII and linked directly to
HepIV in the oligosaccharide chain extension from HepI. In
mutant strain 176lic1, shown to contain a disrupted copy of lic1,
no PCho was present on the HepIII extension, and PCho re-
mained on HepIV (E. Schweda, unpublished results). This find-
ing confirms that lic1 is responsible for the addition of PCho to
the extension off HepIII in NTHI isolate 176 LPS, implying that
similar to NTHI 1158 LPS, lic1* is responsible for addition of
PCho to HepIV.
Functional analysis of lic1 mutant strains. PCho expressed
on the bacterial surface is a target for binding of CRP, an acute-
phase reactant in serum that plays a role in serum killing of the
bacteria. Binding of CRP to the lic1 mutant strains was investi-
gated by Western analysis using an MAb which specifically rec-
ognizes human CRP (Fig. 9). Larger amounts of bound CRP
were detected with the wild-type strain expressing two PCho res-
idues on the LPS than with mutant strain 1158lic1D*, which
expresses one PCho residue. No bound CRP was detected with
mutant strain 1159lic1, which lacks PCho in its LPS.
The resistance of lic1 mutant strains and the parental iso-
lates to the killing effect of pooled human serum and of pooled
human serum with CRP removed was assayed and compared
(Fig. 10). Wild-type strain 1158 and mutant strain 1158lic1D*,
expressing two and one PCho residues, respectively (Fig. 10A
and B), and wild-type strain 1159 and mutant strain 1159lic1,
expressing two and no PCho residues, respectively (Fig. 10C
and D), had relatively similar serum resistance profiles. How-
ever, for strains expressing two or one PCho residue, an in-
crease in serum resistance was evident when CRP was removed
from the serum, whereas no change in serum resistance was
evident with mutant strain 1159lic1, which lacks PCho in its
LPS, when CRP was removed.
Expression of PCho has been reported to play a role in the
persistence of H. influenzae on the mucosal surface of the human
respiratory tract (38), but CRP, also present in the human respi-
ratory tract (6), might be able to block the attachment of PCho-
expressing bacteria to host cells. The association of lic1 mutant
strains and the parental isolates with human airway epithelial cells
(16HBE140
) was assayed. Experiments, carried out in triplicate,
compared the levels of association of NTHI isolates and their lic1
mutants with 16HBE140
 cells in the presence and in the absence
of human serum. NTHI isolate 375 and mutant strain 375lic1
adhered better than strains derived from isolates 1158 and 1159,
but no reproducible trends were observed for parental and mu-
tant strains in these experiments. This indicates that alteration of
the number of PCho molecules attached to the LPS in the NTHI
isolates studied had no significant effect on association of the
bacteria with epithelial cells under our in vitro assay conditions
(data not shown).
DISCUSSION
PCho is a frequent noncarbohydrate substituent of H. influ-
enzae LPS, and its expression is highly variable. This variation
is generated by the lic1D gene sequence, which determines the
site of attachment of PCho within the LPS molecule (17), and
phase variation, which is mediated by a 5CAAT tetranucle-
otide repeat tract located within the lic1A gene (34). PCho can
be linked to a hexose or heptose as part of the oligosaccharide
FIG. 9. Western blot analysis using isogenic strains of H. influenzae
expressing differing amounts of PCho and an MAb against human CRP.
Lane 1, wild-type strain 1158; lane 2, 1158lic1D*; lane 3, 1159lic1.
TABLE 4. Positive-ion ESI-MS data and proposed compositions for oligosaccharide material derived from LPS of NTHI strain 1158lic1D*
Observed [M2H]2
ion (m/z)
Molecular mass (Da)a
Proposed composition
Observed Calculated
823.0 1,644.0 1,645.38 PCho  Ac  Hex2  Hep4  PEtn  AnKdo-ol
b
844.0 1,686.0 1,687.42 PCho  Ac2  Hex2  Hep4  PEtn  AnKdo-ol
850.0 1,698.0 1,699.44 Ac  Gly  Hex3  Hep4  PEtn  AnKdo-ol
865.0 1,728.0 1,729.46 PCho  Ac3  Hex2  Hep4  PEtn  AnKdo-ol
872.0 1,742.0 1,744.47 PCho  Ac2  Gly  Hex2  Hep4  PEtn  AnKdo-ol
886.0 1,770.0 1,771.51 PCho  Ac4  Hex2  Hep4  PEtn  AnKdo-ol
894.0 1,786.0 1,786.52 PCho  Ac3  Gly  Hex2  Hep4  PEtn  AnKdo-ol
907.0 1,812.0 1,813.56 PCho  Ac5  Hex2  Hep4  PEtn  AnKdo-ol
915.0 1,828.0 1,828.57 PCho  Ac4  Gly  Hex2  Hep4  PEtn  AnKdo-ol
925.0 1,848.0 1,849.56 PCho  Ac2  Hex3  Hep4  PEtn  AnKdo-ol
928.0 1,854.0 1,855.61 PCho  Ac6  Hex2  Hep4  PEtn  AnKdo-ol
936.0 1,870.0 1,870.62 PCho  Ac5  Gly  Hex2  Hep4  PEtn  AnKdo-ol
946.0 1,890.0 1,891.61 PCho  Ac3  Hex3  Hep4  PEtn  AnKdo-ol
a Average mass units were used to calculate molecular mass values based on proposed compositions, as follows: Hex, 162.14; Hep, 192.17; AnKdo-ol, 222.20; P, 79.98;
PEtn, 123.05; PCho, 165.13; Ac, 42.04; and Gly, 57.05.
b After O deacylation of the oligosaccharide material with aqueous ammonia, the resulting CE-ESI-MS spectrum revealed a major ion at m/z 802.8 corresponding
to a glycoform with the composition PCho  Hex2  Hep4  PEtn  AnKdo-ol. Minor ions at m/z 787.8 and 883.9 corresponded to PCho  Hex3  Hep3  PEtn  AnKdo-ol
and PCho  Hex3  Hep4  PEtn  AnKdo-ol, respectively.
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FIG. 10. Resistance of lic1 mutant strains and the parental strains to the killing effect of pooled human serum compared to the effect of pooled human
serum with CRP removed. (A) NTHI isolate 1158; (B) mutant strain 1158lic1D*; (C) NTHI isolate 1159; (D) mutant strain 1159lic1. The results are
expressed as a plot of the percentage of survival of inoculating bacteria versus serum concentration. The symbols indicate average values from a single
experiment done in triplicate; the error bars indicate standard deviations. The data are representative of multiple independent experiments.
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extension from any of the three inner core heptoses. PCho
addition to LPS is nonstoichiometric; consequently, not all
LPS glycoforms expressed on the surface of the bacterium are
identical with respect to PCho expression, adding a further
level of heterogeneity. In this study we showed that within a
single LPS molecule the addition of multiple PCho residues is
due to duplication of the genes of the lic1 operon. Phenotypic,
antigenic, and structural analyses of the LPS of lic1 mutant
strains of NTHI provided evidence that each copy of lic1D
specifically directs the addition of PCho to one of two distinct
positions on the LPS molecule. One of these sites of PCho
addition was novel, and addition was directed to a heptose as
part of the oligosaccharide extension from the proximal hep-
tose of the backbone of the LPS inner core. Expression of
multiple PCho residues on a single LPS molecule of nondis-
ease isolates of NTHI has been reported previously (15), po-
tentially indicating a role for this epitope in both the commen-
sal and pathogenic states of the bacterium.
In this study we report that the lic1 operon is duplicated in
4 of the 25 NTHI isolates tested. In three of these four isolates,
the duplication has been shown to be a tandem duplication of
the lic1 operon. In two of the isolates, the genes adjacent to lic1
are also duplicated. Duplicated sequences of HI1535, HI1536,
HI1541 (sppA), and HI1542 were all identified in NTHI isolate
1158. However, with the exception of HI1536 the second cop-
ies of gene sequences were incomplete and therefore would
not be expected to encode additional functional gene products.
The lic1 tandem duplication may have arisen in a single strain,
followed by divergence of the sequence of the distinct copies.
Alternatively, the duplication may have occurred through ac-
quisition of DNA by horizontal transfer from another strain,
where the sequence was already divergent. The organization of
the region of DNA encompassing the lic1 locus, with approx-
imately 6 kb of DNA duplicated in a tandem arrangement, is
potentially unstable and would be expected to undergo high-
frequency loss of the duplication through homologous recom-
bination, analogous to the cap locus in H. influenzae type b
strains. The instability of this region may be reflected by the
fact that the extent of the duplication is distinct in at least three
of the four NTHI isolates possessing two copies of lic1. Exam-
ination of the recently published NTHI genome of isolate
R2846 also revealed a duplication of the lic1 locus, with a
partial lic1B gene and full-length lic1C and lic1D genes, in a
tandem duplication adjacent to a complete lic1 locus. Prelim-
inary data from an LPS structural analysis indicated that two
PCho residues are expressed on the LPS of this isolate (E.
Schweda, unpublished data), likely directed by the two distinct
copies of lic1D, which are homologous to the lic1D alleles of
isolate 1158.
The maintenance of this region of duplicated DNA in the
genome of NTHI suggests that there is positive selection; i.e.,
the phenotype confers increased fitness. In this study, we in-
vestigated lic1 mutant strains to assess the effect of expressing
zero, one, or two PCho residues on the LPS on their associa-
tion with cultured human epithelial cells, binding of CRP, and
resistance to the killing effect of normal human sera. PCho
expression on LPS facilitates colonization and persistence of
NTHI in the human respiratory tract by mediating bacterial
adherence to and invasion of the host epithelia. Swords and
colleagues (30) have demonstrated that a particular subset of
PCho-expressing LPS glycoforms, those highly reactive with
MAb TEPC15, preferentially mediate the interaction of NTHI
with the receptor for platelet-activating factor found on bron-
chial epithelial cells. Conversely, the level and location of
PCho expression can be detrimental to fitness as PCho is a
target for the binding of CRP and subsequent complement-
mediated killing (37, 38). CRP is an acute-phase reactant in
serum which is also expressed on the epithelial surface of the
human respiratory tract (6). In this study, no detectable effect
on association with cultured human epithelial cells was ob-
served when wild-type strains were compared to lic1 mutant
strains. In these types of experiments the findings are often
strain dependent due to the indirect effects of other LPS
epitopes; therefore, similar studies with a range of strain back-
grounds are required to evaluate the effect of various degrees
of PCho decoration on interactions with host cells. A differ-
ence was observed, however, in the binding of CRP to strains
expressing various amounts of PCho, with larger quantities of
CRP bound to strains expressing two PCho residues than to
strains expressing one PCho residue. No detectable CRP was
bound to cells not expressing PCho on their LPS. This finding
is consistent with the work of Weiser and colleagues, who
proposed that PCho is a target for CRP binding and that
bound CRP elicits complement-mediated killing of H. influen-
zae (37, 38). To test whether the levels of bound CRP observed
in strains in this study were related to serum resistance, serum
resistance assays using pooled human serum and pooled hu-
man serum with CRP depleted were performed with wild-type
and lic1 mutant strains. For strains expressing one or two PCho
residues in their LPS, increased serum resistance was observed
when CRP was depleted from the sera, and no corresponding
increase was observed for a strain expressing no PCho. These
findings confirm previous findings suggesting that CRP elicits
bactericidal killing of H. influenzae strains expressing PCho on
their LPS. The expression of one or more PCho residues
would be predicted to increase the susceptibility of H. in-
fluenzae to host clearance during invasive disease. The abil-
ity to vary expression of PCho, therefore, is likely to play an
important role in both the commensal and pathogenic life-
styles of this organism.
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